Preclinical Development of Low Toxicity Drugs

This publication has 12 references indexed in Scilit:

• Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections
  New England Journal of Medicine, 1997
• 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus.
  1995
• Comparative Pulmonary Toxicities and Carcinogenicities of Chronically Inhaled Diesel Exhaust and Carban Black in F344 Rats
  Toxicological Sciences, 1995
• Two-Year Inhalation Exposure of Female and Male B6C3F1 Mice and F344 Rats to Chlorine Gas Induces Lesions Confined to the Nose
  Fundamental and Applied Toxicology, 1995
• Rational design of potent sialidase-based inhibitors of influenza virus replication
  Nature, 1993
• Assessing trends in mortality in 121 U.S. cities, 1970-79, from all causes and from pneumonia and influenza.
  1988
• Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78.
  American Journal of Public Health, 1986
• Morphologic changes in the lung during the lifespan of Fischer 344 rats
  Journal of Anatomy, 1982
• SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS
  Epidemiologic Reviews, 1982
• IMPACT OF EPIDEMIC TYPE A INFLUENZA IN A DEFINED ADULT POPULATION
  American Journal of Epidemiology, 1980